Transplantation of Human Mesenchymal Stem Cells in the Study of Neuropathic Pain
- 7 Citations
- 2.4k Downloads
Abstract
Neuropathic pain is a complex disease that involves several molecular pathways. Due to its individual character, the treatment of neuropathic pain is extremely difficult. Currently available drugs do not affect the mechanisms underlying the generation and propagation of pain. Therefore, pain research is now focused on molecular approaches such as stem cell therapy. Stem cells mediate neuroprotection in a variety of nervous system injury models. We used spared nerve injury (SNI) model of neuropathic pain to assess the possible use of human mesenchymal stem cells (hMSCs) as neuroprotective tool in the regenerative medicine. We conclude that stem cell transplantation could be a useful therapeutic tool in the future of regenerative medicine.
Key words
Neuropathic pain Stem cell therapy Mesenchymal stem cells Stem cell cultureNotes
Acknowledgments
The author would like to thank Prof. Franceso Rossi and Sabatino Maione for funding support, Prof. Umberto Galderisi for his advice and encouragement, Dr. Catia Giordano, Nicola Alessio and Livio Luongo for technical assistance.
References
- 1.Siniscalco D, Rossi F, Maione S (2007) Molecular approaches for neuropathic pain treatment. Curr Med Chem 14:1783–1787PubMedCrossRefGoogle Scholar
- 2.Siniscalco D, Rossi F, Maione S (2008) Stem cell therapy for neuropathic pain treatment. Journal of Stem Cells and Regenerative Medicine vol III (1)Google Scholar
- 3.Beyer Nardi N, da Silva Meirelles L (2006) Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol 174:249–282PubMedGoogle Scholar
- 4.Sethe S, Scutt A, Stolzing A (2006) Aging of mesenchymal stem cells. Ageing Res Rev 5:91–116PubMedCrossRefGoogle Scholar
- 5.Giordano A, Galderisi U, Marino IR (2007) From the laboratory bench to the patient’s bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 211:27–35PubMedCrossRefGoogle Scholar
- 6.Le Blanc K, Pittenger M (2005) Mesenchymal stem cells: progress toward promise. Cytotherapy 7:36–45PubMedGoogle Scholar
- 7.Jori FP, Napolitano MA, Melone MA, Cipollaro M, Cascino A, Altucci L, Peluso G, Giordano A, Galderisi U (2005) Molecular pathways involved in neural in vitro differentiation of marrow stromal stem cells. J Cell Biochem 94:645–655PubMedCrossRefGoogle Scholar
- 8.Bae JS, Han HS, Youn DH, Carter JE, Modo M, Schuchman EH, Jin HK (2007) Bone marrow-derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration. Stem Cells 25:1307–1316PubMedCrossRefGoogle Scholar
- 9.Musolino PL, Coronel MF, Hökfelt T, Villar MJ (2007) Bone marrow stromal cells induce changes in pain behavior after sciatic nerve constriction. Neurosci Lett 418:97–101PubMedCrossRefGoogle Scholar
- 10.Squillaro T, Hayek G, Farina E, Cipollaro M, Renieri A, Galderisi U (2008) A case report: bone marrow mesenchymal stem cells from a Rett syndrome patient are prone to senescence and show a lower degree of apoptosis. J Cell Biochem 103:1877–1885PubMedCrossRefGoogle Scholar
- 11.Bourquin AF, Süveges M, Pertin M, Gilliard N, Sardy S, Davison AC, Spahn DR, Decosterd I (2006) Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse. Pain 122(14):e1-e14PubMedGoogle Scholar
- 12.Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, LondonGoogle Scholar